I would think there would be some interest from new investors with deep pockets over the next two months who might want to get in before the $14m revenue boost. Then a few more prepared to invest for the potential lift up as we head towards approval. Some may see the growing speculation on the rest of the world rights. Finally extremely cautious funds will jump on approval and the initial revenue and massive upside potential.
The dam wall will break, just not sure on the timing.
Ann: Acadia submits Rett Syndrome New Drug Application to the FDA, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.54 |
Change
0.280(2.28%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.52 | $12.73 | $12.26 | $8.152M | 652.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 665 | $12.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.55 | 235 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |